Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Multisite reproducibility of the broth microdilution method for susceptibility testing of Nocardia species.

Conville PS, Brown-Elliott BA, Wallace RJ Jr, Witebsky FG, Koziol D, Hall GS, Killian SB, Knapp CC, Warshauer D, Van T, Wengenack NL, Deml S, Woods GL.

J Clin Microbiol. 2012 Apr;50(4):1270-80. doi: 10.1128/JCM.00994-11. Epub 2012 Jan 4.

2.

"Mycobacterium tilburgii," a newly described, uncultivated opportunistic pathogen.

Palmore TN, Shea YR, Conville PS, Witebsky FG, Anderson VL, Rupp Hodge IP, Holland SM.

J Clin Microbiol. 2009 May;47(5):1585-7. doi: 10.1128/JCM.02385-08. Epub 2009 Mar 4.

3.

Nocardia cyriacigeorgica--an established rather than an emerging pathogen.

Witebsky FG, Conville PS, Wallace RJ Jr, Brown-Elliott BA, Huard RC, Schlaberg R, Della-Latta P.

J Clin Microbiol. 2008 Jul;46(7):2469; author reply 2469-70. doi: 10.1128/JCM.00510-08. No abstract available.

4.

Evaluation of Pyrosequencing technology for the identification of clinically relevant non-dematiaceous yeasts and related species.

Montero CI, Shea YR, Jones PA, Harrington SM, Tooke NE, Witebsky FG, Murray PR.

Eur J Clin Microbiol Infect Dis. 2008 Sep;27(9):821-30. doi: 10.1007/s10096-008-0510-x. Epub 2008 Apr 18.

5.

Nocardia wallacei sp. nov. and Nocardia blacklockiae sp. nov., human pathogens and members of the "Nocardia transvalensis Complex".

Conville PS, Brown JM, Steigerwalt AG, Brown-Elliott BA, Witebsky FG.

J Clin Microbiol. 2008 Apr;46(4):1178-84. doi: 10.1128/JCM.02011-07. Epub 2008 Feb 6.

6.

Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease.

Siddiqui S, Anderson VL, Hilligoss DM, Abinun M, Kuijpers TW, Masur H, Witebsky FG, Shea YR, Gallin JI, Malech HL, Holland SM.

Clin Infect Dis. 2007 Sep 15;45(6):673-81. Epub 2007 Aug 8.

PMID:
17712749
7.
9.

Analysis of secA1 gene sequences for identification of Nocardia species.

Conville PS, Zelazny AM, Witebsky FG.

J Clin Microbiol. 2006 Aug;44(8):2760-6.

11.

Nocardia kruczakiae sp. nov., a pathogen in immunocompromised patients and a member of the "N. nova complex".

Conville PS, Brown JM, Steigerwalt AG, Lee JW, Anderson VL, Fishbain JT, Holland SM, Witebsky FG.

J Clin Microbiol. 2004 Nov;42(11):5139-45.

12.

Evaluation of partial 16S ribosomal DNA sequencing for identification of nocardia species by using the MicroSeq 500 system with an expanded database.

Cloud JL, Conville PS, Croft A, Harmsen D, Witebsky FG, Carroll KC.

J Clin Microbiol. 2004 Feb;42(2):578-84.

13.

"Too numerous to count" lesions on magnetic resonance images of the brain.

Dass K, Shoham S, Monsein L, Conville PS, Witebsky FG, Lucey DR.

Clin Infect Dis. 2003 Jun 15;36(12):1545-6, 1606-8. No abstract available.

PMID:
12807095
14.

Nocardia veterana as a pathogen in North American patients.

Conville PS, Brown JM, Steigerwalt AG, Lee JW, Byrer DE, Anderson VL, Dorman SE, Holland SM, Cahill B, Carroll KC, Witebsky FG.

J Clin Microbiol. 2003 Jun;41(6):2560-8. Erratum in: J Clin Microbiol. 2004 Feb;42(2):939.

15.

Laboratory diagnosis of invasive mycoses.

O'Shaughnessy EM, Shea YM, Witebsky FG.

Infect Dis Clin North Am. 2003 Mar;17(1):135-58. Review.

PMID:
12751264
16.

Multisite reproducibility of results obtained by two broth dilution methods for susceptibility testing of Mycobacterium avium complex.

Woods GL, Williams-Bouyer N, Wallace RJ Jr, Brown-Elliott BA, Witebsky FG, Conville PS, Plaunt M, Hall G, Aralar P, Inderlied C.

J Clin Microbiol. 2003 Feb;41(2):627-31.

17.

Large-scale screening of nasal swabs for Bacillus anthracis: descriptive summary and discussion of the National Institutes of Health's experience.

Kiratisin P, Fukuda CD, Wong A, Stock F, Preuss JC, Ediger L, Brahmbhatt TN, Fischer SH, Fedorko DP, Witebsky FG, Gill VJ.

J Clin Microbiol. 2002 Aug;40(8):3012-6.

18.

Nocardia infection in chronic granulomatous disease.

Dorman SE, Guide SV, Conville PS, DeCarlo ES, Malech HL, Gallin JI, Witebsky FG, Holland SM.

Clin Infect Dis. 2002 Aug 15;35(4):390-4. Epub 2002 Jul 23.

PMID:
12145721
19.

A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Effect of Nystatin on the Development of Oral Irritation in Patients Receiving High-Dose Intravenous Interleukin-2.

Ohnmacht GA, Phan GQ, Mavroukakis SA, Steinberg SM, Shea YR, Witebsky FG, McIntyre LS, Goodwin RS, Muehlbauer PM, Morton KE, Rogers-Freezer LJ, Seipp CA, Rosenberg SA, Marincola FM.

J Immunother (1991). 2001 Mar;24(2):188-192.

PMID:
11449076
20.
21.

A prospective, randomized, double-blind, placebo-controlled trial evaluating the effect of nystatin on the development of oral irritation in patients receiving high-dose intravenous interleukin-2.

Ohnmacht GA, Phan GQ, Mavroukakis SA, Steinberg SM, Shea YR, Witebsky FG, McIntyre LS, Goodwin RS, Muehlbauer PM, Morton KE, Rogers-Freezer LJ, Seipp CA, Rosenberg SA, Marincola FM.

J Immunother. 2001 Mar-Apr;24(2):188-92.

PMID:
11265777
22.

Multisite reproducibility of Etest for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.

Woods GL, Bergmann JS, Witebsky FG, Fahle GA, Boulet B, Plaunt M, Brown BA, Wallace RJ Jr, Wanger A.

J Clin Microbiol. 2000 Feb;38(2):656-61.

23.

Identification of nocardia species by restriction endonuclease analysis of an amplified portion of the 16S rRNA gene.

Conville PS, Fischer SH, Cartwright CP, Witebsky FG.

J Clin Microbiol. 2000 Jan;38(1):158-64.

24.

Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.

Woods GL, Bergmann JS, Witebsky FG, Fahle GA, Wanger A, Boulet B, Plaunt M, Brown BA, Wallace RJ Jr.

J Clin Microbiol. 1999 Jun;37(6):1676-82.

25.

Primary Mycobacterium avium complex infections correlate with lowered cellular immune reactivity in Matschie's tree kangaroos (Dendrolagus matschiei).

Montali RJ, Bush M, Cromie R, Holland SM, Maslow JN, Worley M, Witebsky FG, Phillips TM.

J Infect Dis. 1998 Dec;178(6):1719-25.

PMID:
9815225
26.
27.

Fatal Nocardia pulmonary infection in a child with acquired immunodeficiency syndrome and lymphoid interstitial pneumonitis.

Zwerski S, Witebsky FG, Conville PS, Gill VJ, Freifeld AG.

Pediatr Infect Dis J. 1997 Nov;16(11):1088-9. No abstract available.

PMID:
9384345
28.

Clarithromycin lowers plasma zidovudine levels in persons with human immunodeficiency virus infection.

Polis MA, Piscitelli SC, Vogel S, Witebsky FG, Conville PS, Petty B, Kovacs JA, Davey RT Jr, Walker RE, Falloon J, Metcalf JA, Craft C, Lane HC, Masur H.

Antimicrob Agents Chemother. 1997 Aug;41(8):1709-14.

29.
30.

Identification of mycobacteria by conventional methods.

Witebsky FG, Kruczak-Filipov P.

Clin Lab Med. 1996 Sep;16(3):569-601. Review.

PMID:
8866181
33.

Effect of PANTA on growth of Mycobacterium kansasii in BACTEC 12B medium.

Conville PS, Andrews JW, Witebsky FG.

J Clin Microbiol. 1995 Aug;33(8):2012-5.

35.
37.

Orally administered clarithromycin for the treatment of systemic Mycobacterium avium complex infection in children with acquired immunodeficiency syndrome.

Husson RN, Ross LA, Sandelli S, Inderlied CB, Venzon D, Lewis LL, Woods L, Conville PS, Witebsky FG, Pizzo PA.

J Pediatr. 1994 May;124(5 Pt 1):807-14.

PMID:
8176574
39.

College of American Pathologists position statement regarding rapid detection of Mycobacterium tuberculosis.

Anhalt JP, Witebsky FG, Woods GL.

Arch Pathol Lab Med. 1993 Sep;117(9):873. No abstract available.

PMID:
8368896
40.

The laboratory diagnosis of mycobacterial diseases.

Witebsky FG, Conville PS.

Infect Dis Clin North Am. 1993 Jun;7(2):359-76. Review.

PMID:
8345173
41.

Disseminated infection with Mycobacterium gordonae: report of a case and critical review of the literature.

Weinberger M, Berg SL, Feuerstein IM, Pizzo PA, Witebsky FG.

Clin Infect Dis. 1992 Jun;14(6):1229-39. Review.

PMID:
1623079
42.

Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes.

Lecciones JA, Lee JW, Navarro EE, Witebsky FG, Marshall D, Steinberg SM, Pizzo PA, Walsh TJ.

Clin Infect Dis. 1992 Apr;14(4):875-83.

PMID:
1576282
43.

Invasive infection with Sarcinosporon inkin in a patient with chronic granulomatous disease.

Kenney RT, Kwon-Chung KJ, Witebsky FG, Melnick DA, Malech HL, Gallin JI.

Am J Clin Pathol. 1990 Sep;94(3):344-50.

PMID:
2396608
44.

Characterisation of plasmids extracted from AIDS--associated Mycobacterium avium isolates.

Morris SL, Rouse DA, Malik A, Chaparas SD, Witebsky FG.

Tubercle. 1990 Sep;71(3):181-5.

PMID:
2238124
45.

Inter-bottle transfer of mycobacteria by the BACTEC 460.

Conville PS, Witebsky FG.

Diagn Microbiol Infect Dis. 1989 Sep-Oct;12(5):401-5.

PMID:
2515024
46.

Comparison of three techniques for concentrating positive BACTEC 13A bottles for mycobacterial DNA probe analysis.

Conville PS, Keiser JF, Witebsky FG.

Diagn Microbiol Infect Dis. 1989 Jul-Aug;12(4):309-13.

PMID:
2686912
47.
48.
49.

Comparison of BACTEC 13A medium and Du Pont isolator for detection of mycobacteremia.

Witebsky FG, Keiser JF, Conville PS, Bryan R, Park CH, Walker R, Siddiqi SH.

J Clin Microbiol. 1988 Aug;26(8):1501-5.

50.

Host defense against Mycobacterium-avium complex.

Schnittman S, Lane HC, Witebsky FG, Gosey LL, Hoggan MD, Fauci AS.

J Clin Immunol. 1988 Jul;8(4):234-43.

PMID:
2842366

Supplemental Content

Loading ...
Support Center